Global Breast Reconstruction Market - 2023-2030
Market Overview
The global breast reconstruction market reached US$ 574.33 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 934.30 million by 2030. The market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).
Breast reconstruction uses several plastic surgical techniques to return a breast to a state that is very close to normal after a mastectomy. Implant-based reconstruction and flap reconstruction are the two main types of breast reconstruction. Breast implants are used in implant reconstruction to create a new breast mound. Flap (or autologous) reconstruction creates a new breast using the patient's own tissue from another area of the body.
Market Dynamics
Growing Awareness About Breast Reconstruction Treatment is Driving the Breast Reconstruction Market Growth.
The increase in awareness can be attributed to actions made by independent bodies and market participants. For instance, on October 22, 2021, AbbVie, an implant manufacturer, develops a campaign to showcase reconstruction possibilities. With its new ""Power of You"" campaign, the breast implant manufacturer hopes to change that. The initiative honors patients' bravery and inner fortitude while educating them on their options for breast reconstruction. Although the campaign is unbranded, the company's breast reconstruction products include tissue expanders, implant delivery sleeves, and Natrelle-branded implants.
Additionally, to raise awareness of breast reconstruction, Tata Memorial Centre organized a conference titled Reconstruction and Cancer Care: Enhancing Quality Living with and Beyond Cancer on February 17, 2022. As a result of the aforementioned factors, the breast reconstruction market is anticipated to lead throughout the forecast period.
The Development of 3D-printed Implants May Present Considerable Prospects for Commercial Expansion.
The development of 3D-printed implants may present considerable prospects for commercial expansion. For instance, on April 06, 2023, Breast implants will be bioprinted by CollPlant and Stratasys. The company has a significant chance to use bioprinting to alter healthcare and better the lives of patients undergoing breast augmentation or repair treatments thanks to its cooperation with CollPlant.
To advance the development of bioprinting technology, CollPlant, and Stratasys inked a combined development and commercialization agreement. The collaboration will pair Stratasys' P3 technology-based bioprinter with CollPlant's rhCollagen-based bio-inks. Programmable PhotoPolymerization, also known as P3, is a development of digital light processing (DLP) technology intended for the bulk manufacturing of useful end-use components.
COVID-19 Impact Analysis
The market was temporarily impacted by the COVID-19 pandemic, mostly during the pandemic's early stages. The ongoing and scheduled surgical procedures were postponed or canceled as a result of the limitations and lockout, which hampered the expansion of the breast implant market. However, during the COVID-19 pandemic among women in the United States, interest and growing awareness regarding physical appearance, including breast augmentation and implants, increased. As a result, the market is anticipated to rebound from the COVID-19 pandemic's effects and develop.
Russia-Ukraine War Impact Analysis
The Russia-Ukraine is estimated to have a minimal impact on the global breast reconstruction market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global Breast reconstruction market in the forecast period.
Artificial Intelligence Impact Analysis
Artificial intelligence is anticipated to impact the global breast reconstruction market positively owing to the Breast Advocate app being the first shared decision-making tool for breast reconstruction and cancer surgery in the world. It is a free app that gives anybody with a breast cancer diagnosis or at risk of getting breast cancer a voice in the choices made about their surgery. It was co-created by breast cancer doctors and patient activists.
Segment Analysis
The global breast reconstruction market is segmented based on product type, shape, placement, end-user, and region.
The Round Shape Segment is Estimated to Hold a Majority of the Breast Reconstruction Market Share During the Forecast Period.
The round shape holds about 56% of the total breast reconstruction market in the forecast period owing to the acceptance of new products by different permitting bodies. The dominance can be due to the increase in product announcements, the FDA's regular updates on the safety of breast implants, and the execution of several clinical investigations.
For instance, GC Aesthetics will introduce the PERLE, a new generation of round silicone breast implants, in May 2021. In order to ensure that patients undergoing breast implant surgery have enough information, the U.S. FDA amended its safety guidelines for breast implants in October 2021 and prohibited the sales and distribution of breast implants. Therefore, round-shaped breast implants are anticipated to experience significant growth as a result of the aforementioned factors.
Geographical Analysis
Asia Pacific is Estimated to Hold the Second-largest Share of the Global Breast Reconstruction Market During the Forecast Period.
The Asia Pacific region holds the second largest share of the global breast reconstruction market accounting for approximately 33% in the forecast period. The rise in awareness of breast reconstruction surgery and the fast-rising breast cancer population are both responsible for the growth.
For instance, the NCBI data revealed that there were approximately 303,600 new instances of breast cancer and 70,400 fatalities from the disease in China. Furthermore, according to a similar source, the incidence rate and mortality rate in China are predicted to rise by 2030 due to changing demographics and risks. More than 76.5% of women preferred breast reconstruction following mastectomy, according to research by a similar source.
Competitive Landscape
The major global players in the market include Allergan Plc, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A., GC Aesthetics, Groupe Sebbin SAS, Ideal Implant Incorporated, Laboratoires Arion, and Mentor Worldwide LLC, among others.
Why Purchase the Report?
• To visualize the global breast reconstruction market segmentation based on product type, shape, placement, end user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of breast reconstruction market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global Breast reconstruction market report would provide approximately 69 tables, 66 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Product Type
- 3.2. Snippet by Shape
- 3.3. Snippet by Placement
- 3.4. Snippet by End User
- 3.5. Snippet by Region
- 4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. The increasing prevalence of breast cancer worldwide is expected to drive market growth.
- 4.1.1.2. Growing Awareness about breast reconstruction treatment
- 4.1.2. Restraints
- 4.1.2.1. The high cost of breast surgical procedures is expected to hamper the market growth
- 4.1.3. Opportunity
- 4.1.3.1. The introduction of 3D-printed implants may present significant advantages market expansion opportunities
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Forces Analysis
- 5.2. Supply Chain Analysis
- 5.3. Unmet Needs
- 5.4. Regulatory Analysis
- 6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Before COVID-19 Scenario
- 6.1.2. Present COVID-19 Scenario
- 6.1.3. Post COVID-19 or Future Scenario
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During the Pandemic
- 6.5. Manufacturers’ Strategic Initiatives
- 6.6. Conclusion
- 7. Russia-Ukraine War Analysis
- 8. Artificial Intelligence Impact Analysis
- 9. By Product Type
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.1.2. Market Attractiveness Index, By Product Type
- 9.2. Implants
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Tissue Expander
- 9.4. Acellular Dermal Matrix
- 10. By Shape
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
- 10.1.2. Market Attractiveness Index, By Shape
- 10.2. Round Shape
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. Anatomical Shape
- 11. By Placement
- 11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
- 11.1.2. Market Attractiveness Index, By Placement
- 11.2. Dual Plane Insertion
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 11.3. Subglandular Insertion
- 11.4. Submuscular Insertion
- 12. By End User
- 12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12.1.2. Market Attractiveness Index, By End User
- 12.2. Hospitals
- 12.2.1. Introduction
- 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 12.3. Ambulatory Surgical Centers
- 12.4. Others
- 13. By Region
- 13.1. Introduction
- 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 13.1.2. Market Attractiveness Index, By Region
- 13.2. North America
- 13.2.1. Introduction
- 13.2.2. Key Region-Specific Dynamics
- 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
- 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
- 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 13.2.7.1. The U.S.
- 13.2.7.2. Canada
- 13.2.7.3. Mexico
- 13.3. Europe
- 13.3.1. Introduction
- 13.3.2. Key Region-Specific Dynamics
- 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
- 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
- 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 13.3.7.1. Germany
- 13.3.7.2. The U.K.
- 13.3.7.3. France
- 13.3.7.4. Italy
- 13.3.7.5. Russia
- 13.3.7.6. Rest of Europe
- 13.4. South America
- 13.4.1. Introduction
- 13.4.2. Key Region-Specific Dynamics
- 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
- 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
- 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 13.4.7.1. Brazil
- 13.4.7.2. Argentina
- 13.4.7.3. Rest of South America
- 13.5. Asia-Pacific
- 13.5.1. Introduction
- 13.5.2. Key Region-Specific Dynamics
- 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
- 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
- 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 13.5.7.1. China
- 13.5.7.2. India
- 13.5.7.3. Japan
- 13.5.7.4. Australia
- 13.5.7.5. Rest of Asia-Pacific
- 13.6. Middle East and Africa
- 13.6.1. Introduction
- 13.6.2. Key Region-Specific Dynamics
- 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Shape
- 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
- 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 14. Competitive Landscape
- 14.1. Competitive Scenario
- 14.2. Market Share Analysis
- 14.3. Mergers and Acquisitions Analysis
- 15. Company Profiles
- 15.1. Allergan Plc
- 15.1.1. Company Overview
- 15.1.2. Product Type Portfolio and Description
- 15.1.3. Financial Overview
- 15.1.4. Key Developments
- 15.2. Sientra, Inc
- 15.3. IDEAL IMPLANT INCORPORATED
- 15.4. Johnson & Johnson
- 15.5. Establishment Labs S.A.
- 15.6. GC Aesthetics
- 15.7. Groupe Sebbin SAS
- 15.8. Ideal Implant Incorporated
- 15.9. Laboratoires Arion
- 15.10. Mentor Worldwide LLC.
- LIST NOT EXHAUSTIVE
- 16. Appendix
- 16.1. About Us and Services
- 16.2. Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook